Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
TFC Therapeutics Launches to Advance Novel Platform and Technologies in Cancer Biology
Details : The agreement aims to develop a drug discovery platform that targets Tumor Macrophage Hybrid (TMH) cells to eliminate the most resilient cancers and stop disease recurrence.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 17, 2023